Analgesic effects of RodeMyr®, a Commiphora molmol extract with a highly standardized furanodiene content

Furanoeudesma-1,3-diene, curzerene and lindestrene are thought to be the active principles underlying the analgesic action of myrrh (Commiphora molmol) extract. Recently, a very highly standardized dry extract from myrrh has been developed (RodeMyr®) and formulated in a single active nutritional supplement (Mirra+®), notified to the Italian Health Authorities in 2018. We have therefore used such a finished product to evaluate the analgesic action of myrrh in subjects affected by chronic pain. The results of the study have shown that the use of 100 mg of dry myrrh extract, administered twice a day, is effective in reducing pain perception and functio laesa both as a sole and an add-on therapy. Tolerability, compliance and side effect evaluation demonstrated the safety profile of the extract and its usefulness in treating patients with chronic pain.